Avoro Capital Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Avoro Capital Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$952M	Buy	1,818,181 +10,681	+0.6%	+$5.1M	9.38%	3
2025 Q4	$1.05B	Sell	1,807,500 -25,500	-1%	-$13M	10.35%	3
2025 Q3	$841M	Sell	1,833,000 -42,000	-2%	-$15.7M	10.88%	3
2025 Q2	$567M	Sell	1,875,000 -147,222	-7%	-$43.9M	9.94%	4
2025 Q1	$670M	Sell	2,022,222 -6,778	-0.3%	-$2.23M	10.46%	4
2024 Q4	$626M	Hold	2,029,000	–	–	8.86%	4
2024 Q3	$431M	Sell	2,029,000 -26,555	-1%	-$6.79M	6.28%	5
2024 Q2	$576M	Buy	2,055,555 +111,111	+6%	+$26.4M	7.67%	2
2024 Q1	$519M	Buy	1,944,444 +55,556	+3%	+$13.1M	6.06%	5
2023 Q4	$437M	Buy	1,888,888 +333,888	+21%	+$58.4M	6.04%	5
2023 Q3	$227M	Buy	1,555,000 +39,849	+3%	+$7.5M	3.54%	12
2023 Q2	$350M	Sell	1,515,151 -151,515	-9%	-$41M	4.75%	6
2023 Q1	$404M	Buy	1,666,666 +6,666	+0.4%	+$1.82M	5.99%	6
2022 Q4	$482M	Buy	1,660,000 +125,000	+8%	+$12.2M	7.2%	4
2022 Q3	$99.8M	Hold	1,535,000	–	–	1.84%	15
2022 Q2	$110M	Buy	1,535,000 +110,000	+8%	+$8.09M	2.17%	13
2022 Q1	$140M	Hold	1,425,000	–	–	2.55%	15
2021 Q4	$121M	Hold	1,425,000	–	–	2.06%	14
2021 Q3	$114M	Hold	1,425,000	–	–	1.79%	16
2021 Q2	$139M	Hold	1,425,000	–	–	2.42%	12
2021 Q1	$167M	Buy	1,425,000 +200,000	+16%	+$23.3M	2.88%	10
2020 Q4	$136M	Buy	1,225,000 +335,000	+38%	+$40.9M	2.35%	13
2020 Q3	$106M	Buy	890,000 +540,000	+154%	+$58.6M	1.5%	14
2020 Q2	$39.6M	Buy	350,000 +1,000	+0.3%	+$98.3K	0.78%	25
2020 Q1	$23.3M	Hold	349,000	–	–	0.79%	27
2019 Q4	$31.8M	Sell	349,000 -11,000	-3%	-$1.07M	0.94%	19
2019 Q3	$31M	Hold	360,000	–	–	1.29%	20
2019 Q2	$37.7M	Buy	360,000 +50,000	+16%	+$5.36M	1.31%	18
2019 Q1	$38.8M	Buy	310,000 +85,000	+38%	+$10.6M	1.68%	18
2018 Q4	$25.4M	Sell	225,000 -238,000	-51%	-$36.8M	1.52%	15
2018 Q3	$99.1M	Sell	463,000 -26,536	-5%	-$6.66M	4.56%	7
2018 Q2	$137M	Buy	+489,536	New	+$86M	5.28%	6